<p>大都會人壽 (NYSE:MET - 獲取免費報告) 在週二發佈的研究報告中，將其目標價格從 92.00 美元上調至 94.00 美元，摩根士丹利公司對此進行了報道。該券商目前對該金融服務提供商的股票給予 “增持” 評級。摩根士丹利公司的目標價格暗示該股票相較於前一交易日收盤價有 15.69% 的上漲潛力。</p>
<ul>
<li>3 只金融股票讓投資者感到失望</li>
</ul>
<p>其他幾位分析師也對 MET 發佈了報告。Weiss Ratings 在 12 月 15 日的研究報告中重申了對大都會人壽股票的 “持有（c+）” 評級。瑞穗證券在 12 月 15 日的研究報告中開始覆蓋大都會人壽股票，給予 “跑贏大盤” 評級，並設定 101.00 美元的目標價格。派珀·桑德勒將大都會人壽的評級從 “增持” 下調至 “中性”，並在 9 月 19 日的報告中設定了 84.00 美元的目標價格。摩根士丹利在 12 月 15 日的研究報告中設定了 101.00 美元的目標價格，並給予該股票 “增持” 評級。最後，Keefe, Bruyette &amp; Woods 在 11 月 11 日的報告中將大都會人壽的目標價格從 92.00 美元下調至 90.00 美元，並對該股票給予 “跑贏大盤” 評級。兩位投資分析師對該股票給予強烈買入評級，八位分析師給予買入評級，三位分析師給予持有評級。根據 MarketBeat.com 的數據，大都會人壽目前的共識評級為 “適度買入”，平均目標價格為 95.73 美元。</p>
<p><strong>查看我們最新的 MET 股票報告</strong></p>
<h2>大都會人壽價格表現</h2>
<ul>
<li>2 只保險股票即將大幅突破</li>
</ul>
<p>大都會人壽股票在週二下跌 0.10 美元，報 81.26 美元。該股票交易量為 53,401 股，而其平均交易量為 3,431,109 股。該公司的市值為 535.4 億美元，市盈率為 15.30，市盈增長比率為 0.78，貝塔值為 0.76。大都會人壽的年內最低價為 65.21 美元，最高價為 88.09 美元。該公司的債務與股本比率為 0.54，速動比率為 0.18，流動比率為 0.18。該公司的 50 日移動平均線為 78.52 美元，200 日移動平均線為 78.90 美元。</p>
<p>大都會人壽 (NYSE:MET - 獲取免費報告) 最近於 11 月 5 日發佈了季度財報。該金融服務提供商報告每股收益為 2.37 美元，超出市場共識預期的 2.30 美元，超出幅度為 0.07 美元。該公司本季度的收入為 124.6 億美元，而分析師預期為 186.4 億美元。大都會人壽的淨利潤率為 5.30%，股本回報率為 21.00%。該公司本季度的收入較去年同期下降了 5.9%。在去年同期，該公司每股收益為 1.95 美元。整體來看，分析師預計大都會人壽在當前財年將發佈 9.65 美元的每股收益。</p>
<h2>對大都會人壽的對沖基金看法</h2>
<ul>
<li>MarketBeat 週迴顧 – 8/21 - 8/25</li>
</ul>
<p>一些對沖基金最近增加或減少了對該公司的持股。Brighton Jones LLC 在第四季度將其在大都會人壽的持股增加了 9.0%。Brighton Jones LLC 目前擁有大都會人壽的 4,240 股股票，價值 347,000 美元，此前在上個季度購買了 351 股。AlphaQuest LLC 在第一季度將其在大都會人壽的持股增加了 569.9%。AlphaQuest LLC 目前擁有 891 股大都會人壽的股票，價值 72,000 美元，此前在此期間又購買了 758 股。西北互助財富管理公司在第一季度將其在大都會人壽的持股增加了 58.6%。西北互助財富管理公司目前擁有 63,051 股大都會人壽的股票，價值 5,062,000 美元，此前在此期間又購買了 23,297 股。ICONIQ Capital LLC 在第一季度將其在大都會人壽的持股增加了 14.3%。ICONIQ Capital LLC 目前擁有 3,738 股大都會人壽的股票，價值 300,000 美元，此前在此期間又購買了 469 股。最後，Comerica Bank 在第一季度將其在大都會人壽的持股增加了 2.9%。Comerica Bank 目前擁有 210,808 股大都會人壽的股票，價值 16,926,000 美元，此前在此期間又購買了 5,955 股。機構投資者和對沖基金持有該公司 94.99% 的股票。</p>
<h2>關於大都會人壽</h2>
<p>(獲取免費報告)</p>
<p>大都會人壽公司是一家全球保險、年金和員工福利計劃的提供商。公司總部位於紐約市，向個人、僱主和機構客户提供一系列風險保護和退休解決方案。其核心業務包括人壽保險、團體福利、年金等退休產品，以及包括牙科和殘疾保險在內的補充健康產品。</p>
<p>除了傳統的人壽和團體保險外，大都會人壽還提供通過僱主贊助計劃分發的工作場所福利和自願產品。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票超過大都會人壽</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微型 “3 美元 AI 奇蹟股票” 即將爆發</li>
<li>有哪些費用可以從資本利得税中扣除？</li>
<li>巴菲特、蓋茨和貝索斯悄然拋售股票——原因在這裏</li>
<li>你知道亞馬遜計劃在 1 月 1 日做什麼嗎？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1FVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1FVA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在大都會人壽嗎？</h2>
<p>在考慮大都會人壽之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而大都會人壽並不在名單上。</p>
<p>雖然大都會人壽目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

大都會人壽

富國銀行

<p>富國銀行將大都會人壽的目標股價從 92.00 美元上調至 94.00 美元，維持 “增持” 評級，暗示潛在上漲幅度為 15.69%。其他分析師的評級則各有不同，普遍共識為 “適度買入”，平均目標股價為 95.73 美元。大都會人壽最近的財報超出預期，對沖基金也調整了在該公司的持倉</p>

<p>MetLife (NYSE:MET - Get Free Report) had its price objective hoisted by Wells Fargo &amp; Company from $92.00 to $94.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has an &#34;overweight&#34; rating on the financial services provider's stock. Wells Fargo &amp; Company's price target suggests a potential upside of 15.69% from the stock's previous close.</p>
<div class="lb-trans"><p>大都會人壽 (NYSE:MET - 獲取免費報告) 在週二發佈的研究報告中，將其目標價格從 92.00 美元上調至 94.00 美元，摩根士丹利公司對此進行了報道。該券商目前對該金融服務提供商的股票給予 “增持” 評級。摩根士丹利公司的目標價格暗示該股票相較於前一交易日收盤價有 15.69% 的上漲潛力。</p>
</div><ul>
<li>3 Finance Stocks Leaving Coal in Investors Stockings</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只金融股票讓投資者感到失望</li>
</ul>
</div><p>Several other analysts have also issued reports on MET. Weiss Ratings restated a &#34;hold (c+)&#34; rating on shares of MetLife in a research report on Monday, December 15th. Mizuho initiated coverage on shares of MetLife in a research note on Monday, December 15th. They set an &#34;outperform&#34; rating and a $101.00 target price on the stock. Piper Sandler cut MetLife from an &#34;overweight&#34; rating to a &#34;neutral&#34; rating and set a $84.00 price target for the company. in a report on Friday, September 19th. Morgan Stanley set a $101.00 price target on MetLife and gave the stock an &#34;overweight&#34; rating in a research report on Monday, December 15th. Finally, Keefe, Bruyette &amp; Woods reduced their target price on shares of MetLife from $92.00 to $90.00 and set an &#34;outperform&#34; rating on the stock in a report on Tuesday, November 11th. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, MetLife presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $95.73.</p>
<div class="lb-trans"><p>其他幾位分析師也對 MET 發佈了報告。Weiss Ratings 在 12 月 15 日的研究報告中重申了對大都會人壽股票的 “持有（c+）” 評級。瑞穗證券在 12 月 15 日的研究報告中開始覆蓋大都會人壽股票，給予 “跑贏大盤” 評級，並設定 101.00 美元的目標價格。派珀·桑德勒將大都會人壽的評級從 “增持” 下調至 “中性”，並在 9 月 19 日的報告中設定了 84.00 美元的目標價格。摩根士丹利在 12 月 15 日的研究報告中設定了 101.00 美元的目標價格，並給予該股票 “增持” 評級。最後，Keefe, Bruyette &amp; Woods 在 11 月 11 日的報告中將大都會人壽的目標價格從 92.00 美元下調至 90.00 美元，並對該股票給予 “跑贏大盤” 評級。兩位投資分析師對該股票給予強烈買入評級，八位分析師給予買入評級，三位分析師給予持有評級。根據 MarketBeat.com 的數據，大都會人壽目前的共識評級為 “適度買入”，平均目標價格為 95.73 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on MET</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 MET 股票報告</strong></p>
</div><h2>MetLife Price Performance</h2>
<div class="lb-trans"><h2>大都會人壽價格表現</h2>
</div><ul>
<li>2 Insurance Stocks Poised For Major Breakouts</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只保險股票即將大幅突破</li>
</ul>
</div><p>Shares of MetLife stock traded down $0.10 on Tuesday, reaching $81.26. 53,401 shares of the stock were exchanged, compared to its average volume of 3,431,109. The firm has a market cap of $53.54 billion, a PE ratio of 15.30, a P/E/G ratio of 0.78 and a beta of 0.76. MetLife has a one year low of $65.21 and a one year high of $88.09. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.18 and a current ratio of 0.18. The firm's 50 day moving average is $78.52 and its 200-day moving average is $78.90.</p>
<div class="lb-trans"><p>大都會人壽股票在週二下跌 0.10 美元，報 81.26 美元。該股票交易量為 53,401 股，而其平均交易量為 3,431,109 股。該公司的市值為 535.4 億美元，市盈率為 15.30，市盈增長比率為 0.78，貝塔值為 0.76。大都會人壽的年內最低價為 65.21 美元，最高價為 88.09 美元。該公司的債務與股本比率為 0.54，速動比率為 0.18，流動比率為 0.18。該公司的 50 日移動平均線為 78.52 美元，200 日移動平均線為 78.90 美元。</p>
</div><p>MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.30 by $0.07. The business had revenue of $12.46 billion for the quarter, compared to analysts' expectations of $18.64 billion. MetLife had a net margin of 5.30% and a return on equity of 21.00%. The firm's revenue for the quarter was down 5.9% compared to the same quarter last year. During the same period in the previous year, the company earned $1.95 earnings per share. As a group, analysts anticipate that MetLife will post 9.65 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>大都會人壽 (NYSE:MET - 獲取免費報告) 最近於 11 月 5 日發佈了季度財報。該金融服務提供商報告每股收益為 2.37 美元，超出市場共識預期的 2.30 美元，超出幅度為 0.07 美元。該公司本季度的收入為 124.6 億美元，而分析師預期為 186.4 億美元。大都會人壽的淨利潤率為 5.30%，股本回報率為 21.00%。該公司本季度的收入較去年同期下降了 5.9%。在去年同期，該公司每股收益為 1.95 美元。整體來看，分析師預計大都會人壽在當前財年將發佈 9.65 美元的每股收益。</p>
</div><h2>Hedge Funds Weigh In On MetLife</h2>
<div class="lb-trans"><h2>對大都會人壽的對沖基金看法</h2>
</div><ul>
<li>MarketBeat Week in Review – 8/21 - 8/25</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 8/21 - 8/25</li>
</ul>
</div><p>A number of hedge funds have recently added to or reduced their stakes in the business. Brighton Jones LLC increased its holdings in MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock valued at $347,000 after purchasing an additional 351 shares during the last quarter. AlphaQuest LLC grew its position in shares of MetLife by 569.9% in the 1st quarter. AlphaQuest LLC now owns 891 shares of the financial services provider's stock valued at $72,000 after acquiring an additional 758 shares during the period. Northwestern Mutual Wealth Management Co. raised its position in shares of MetLife by 58.6% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 63,051 shares of the financial services provider's stock valued at $5,062,000 after purchasing an additional 23,297 shares during the period. ICONIQ Capital LLC increased its position in MetLife by 14.3% during the 1st quarter. ICONIQ Capital LLC now owns 3,738 shares of the financial services provider's stock worth $300,000 after buying an additional 469 shares during the period. Finally, Comerica Bank boosted its holdings in MetLife by 2.9% in the 1st quarter. Comerica Bank now owns 210,808 shares of the financial services provider's stock valued at $16,926,000 after purchasing an additional 5,955 shares during the period. Institutional investors and hedge funds own 94.99% of the company's stock.</p>
<div class="lb-trans"><p>一些對沖基金最近增加或減少了對該公司的持股。Brighton Jones LLC 在第四季度將其在大都會人壽的持股增加了 9.0%。Brighton Jones LLC 目前擁有大都會人壽的 4,240 股股票，價值 347,000 美元，此前在上個季度購買了 351 股。AlphaQuest LLC 在第一季度將其在大都會人壽的持股增加了 569.9%。AlphaQuest LLC 目前擁有 891 股大都會人壽的股票，價值 72,000 美元，此前在此期間又購買了 758 股。西北互助財富管理公司在第一季度將其在大都會人壽的持股增加了 58.6%。西北互助財富管理公司目前擁有 63,051 股大都會人壽的股票，價值 5,062,000 美元，此前在此期間又購買了 23,297 股。ICONIQ Capital LLC 在第一季度將其在大都會人壽的持股增加了 14.3%。ICONIQ Capital LLC 目前擁有 3,738 股大都會人壽的股票，價值 300,000 美元，此前在此期間又購買了 469 股。最後，Comerica Bank 在第一季度將其在大都會人壽的持股增加了 2.9%。Comerica Bank 目前擁有 210,808 股大都會人壽的股票，價值 16,926,000 美元，此前在此期間又購買了 5,955 股。機構投資者和對沖基金持有該公司 94.99% 的股票。</p>
</div><h2>About MetLife</h2>
<div class="lb-trans"><h2>關於大都會人壽</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.</p>
<div class="lb-trans"><p>大都會人壽公司是一家全球保險、年金和員工福利計劃的提供商。公司總部位於紐約市，向個人、僱主和機構客户提供一系列風險保護和退休解決方案。其核心業務包括人壽保險、團體福利、年金等退休產品，以及包括牙科和殘疾保險在內的補充健康產品。</p>
</div><p>In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.</p>
<div class="lb-trans"><p>除了傳統的人壽和團體保險外，大都會人壽還提供通過僱主贊助計劃分發的工作場所福利和自願產品。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than MetLife</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
<li>Do you know what Amazon is planning for January 1?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過大都會人壽</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微型 “3 美元 AI 奇蹟股票” 即將爆發</li>
<li>有哪些費用可以從資本利得税中扣除？</li>
<li>巴菲特、蓋茨和貝索斯悄然拋售股票——原因在這裏</li>
<li>你知道亞馬遜計劃在 1 月 1 日做什麼嗎？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1FVA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=MET"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in MetLife Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在大都會人壽嗎？</h2>
</div><p>Before you consider MetLife, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮大都會人壽之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而大都會人壽並不在名單上。</p>
</div><p>While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然大都會人壽目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

富國銀行將大都會人壽（NYSE:MET）的目標股價上調至 94.00 美元